Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

273 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of a Digital Research Assistant for the Management of Patients' Enrollment in Oncology Clinical Trials within a Research Hospital.
Cesario A, Simone I, Paris I, Boldrini L, Orlandi A, Franceschini G, Lococo F, Bria E, Magno S, Mulè A, Santoro A, Damiani A, Bianchi D, Picchi D, Rasi G, Daniele G, Fabi A, Sergi P, Tortora G, Masetti R, Valentini V, D'Oria M, Scambia G. Cesario A, et al. Among authors: daniele g. J Pers Med. 2021 Mar 27;11(4):244. doi: 10.3390/jpm11040244. J Pers Med. 2021. PMID: 33801668 Free PMC article.
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis.
Mastrantoni L, Orlandi A, Palazzo A, Garufi G, Fabi A, Daniele G, Giannarelli D, Tortora G, Bria E. Mastrantoni L, et al. Among authors: daniele g. EClinicalMedicine. 2023 Jan 20;56:101824. doi: 10.1016/j.eclinm.2023.101824. eCollection 2023 Feb. EClinicalMedicine. 2023. PMID: 36713467 Free PMC article.
Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis.
Filetti M, Lombardi P, Falcone R, Giusti R, Giannarelli D, Carcagnì A, Altamura V, Scambia G, Daniele G. Filetti M, et al. Among authors: daniele g. Explor Target Antitumor Ther. 2023;4(6):1136-1144. doi: 10.37349/etat.2023.00187. Epub 2023 Dec 1. Explor Target Antitumor Ther. 2023. PMID: 38213541 Free PMC article.
Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials.
Duranti S, Fabi A, Filetti M, Falcone R, Lombardi P, Daniele G, Franceschini G, Carbognin L, Palazzo A, Garganese G, Paris I, Scambia G, Pietragalla A. Duranti S, et al. Among authors: daniele g. Cancers (Basel). 2021 Oct 16;13(20):5198. doi: 10.3390/cancers13205198. Cancers (Basel). 2021. PMID: 34680350 Free PMC article. Review.
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go.
De Maria Marchiano R, Di Sante G, Piro G, Carbone C, Tortora G, Boldrini L, Pietragalla A, Daniele G, Tredicine M, Cesario A, Valentini V, Gallo D, Babini G, D'Oria M, Scambia G. De Maria Marchiano R, et al. Among authors: daniele g. J Pers Med. 2021 Mar 18;11(3):216. doi: 10.3390/jpm11030216. J Pers Med. 2021. PMID: 33803592 Free PMC article. Review.
The Role of Artificial Intelligence in Managing Multimorbidity and Cancer.
Cesario A, D'Oria M, Calvani R, Picca A, Pietragalla A, Lorusso D, Daniele G, Lohmeyer FM, Boldrini L, Valentini V, Bernabei R, Auffray C, Scambia G. Cesario A, et al. Among authors: daniele g. J Pers Med. 2021 Apr 19;11(4):314. doi: 10.3390/jpm11040314. J Pers Med. 2021. PMID: 33921621 Free PMC article. Review.
273 results